Tas, F. Et Al. 2016. Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.. American journal of therapeutics , vol.23, no.3 .

Tas, F., Yildiz, I., Kilic, L., Ciftci, R., Keskin, S., & Sen, F., (2016). Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.. American journal of therapeutics , vol.23, no.3.

Tas, Faruk Et Al. "Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.," American journal of therapeutics , vol.23, no.3, 2016

Tas, Faruk Et Al. "Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.." American journal of therapeutics , vol.23, no.3, 2016

Tas, F. Et Al. (2016) . "Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.." American journal of therapeutics , vol.23, no.3.

@article{article, author={Faruk TAŞ Et Al. }, title={Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.}, journal={American journal of therapeutics}, year=2016}